1. Home
  2. PULM vs ZEPP Comparison

PULM vs ZEPP Comparison

Compare PULM & ZEPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • ZEPP
  • Stock Information
  • Founded
  • PULM 2003
  • ZEPP 2013
  • Country
  • PULM United States
  • ZEPP Netherlands
  • Employees
  • PULM N/A
  • ZEPP N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • ZEPP Computer Manufacturing
  • Sector
  • PULM Health Care
  • ZEPP Technology
  • Exchange
  • PULM Nasdaq
  • ZEPP Nasdaq
  • Market Cap
  • PULM 33.2M
  • ZEPP 34.1M
  • IPO Year
  • PULM N/A
  • ZEPP N/A
  • Fundamental
  • Price
  • PULM $7.43
  • ZEPP $2.43
  • Analyst Decision
  • PULM
  • ZEPP
  • Analyst Count
  • PULM 0
  • ZEPP 0
  • Target Price
  • PULM N/A
  • ZEPP N/A
  • AVG Volume (30 Days)
  • PULM 34.2K
  • ZEPP 18.9K
  • Earning Date
  • PULM 08-12-2025
  • ZEPP 05-19-2025
  • Dividend Yield
  • PULM N/A
  • ZEPP N/A
  • EPS Growth
  • PULM N/A
  • ZEPP N/A
  • EPS
  • PULM N/A
  • ZEPP N/A
  • Revenue
  • PULM $1,921,000.00
  • ZEPP $181,183,000.00
  • Revenue This Year
  • PULM N/A
  • ZEPP $758.69
  • Revenue Next Year
  • PULM $134.88
  • ZEPP N/A
  • P/E Ratio
  • PULM N/A
  • ZEPP N/A
  • Revenue Growth
  • PULM N/A
  • ZEPP N/A
  • 52 Week Low
  • PULM $1.78
  • ZEPP $2.06
  • 52 Week High
  • PULM $10.40
  • ZEPP $4.38
  • Technical
  • Relative Strength Index (RSI)
  • PULM 49.28
  • ZEPP 47.59
  • Support Level
  • PULM $8.49
  • ZEPP $2.25
  • Resistance Level
  • PULM $8.75
  • ZEPP $2.44
  • Average True Range (ATR)
  • PULM 0.42
  • ZEPP 0.14
  • MACD
  • PULM -0.14
  • ZEPP 0.00
  • Stochastic Oscillator
  • PULM 0.11
  • ZEPP 49.90

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About ZEPP Zepp Health Corporation

Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.

Share on Social Networks: